SCHEMBL3640494

SCHEMBL3640494

Cc1ccc(CC(=O)C(C)Cl)cc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.45
ALDH1A1 P00352 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KDM4E B2RXH2 1/20 0.41
CA1 P00915 1/20 0.41
CCR2 P41597 1/20 0.40
CHRNA1 P02708 1/20 0.40
CHRNG P07510 1/20 0.40
CHRNB1 P11230 1/20 0.40
CHRNB2 P17787 1/20 0.40
SLC6A2 P23975 1/20 0.40
CHRNB4 P30926 1/20 0.40
SLC6A4 P31645 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
SLC6A3 Q01959 1/20 0.40
CHRND Q07001 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
AGTR1 P30556 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3633304 0.86 PNMT (0.49) CA2
SCHEMBL1403495 0.82 CA2 (0.65) CA2ALDH1A1NPSR1KDM4ECA1
SCHEMBL15181144 0.79 CA2 (0.46) CA2ALDH1A1NPSR1KDM4ECA1
SCHEMBL4685210 0.77 CA2 (0.47) CA2ALDH1A1NPSR1KDM4ECA1
SCHEMBL4685207 0.77 CA2 (0.44) CA2ALDH1A1NPSR1KDM4ECA1
SCHEMBL2655186 0.77 CA2 (0.44) CA2ALDH1A1NPSR1KDM4ECA1
SCHEMBL2164370 0.76 CA2 (0.47) CA2ALDH1A1NPSR1KDM4ECA1
SCHEMBL3637432 0.75 IDO1 (0.48) KDM4EMAPT
SCHEMBL14621890 0.75 ALDH1A1 (0.42) CA2ALDH1A1NPSR1KDM4ECA1
SCHEMBL10229485 0.75 ALDH1A1 (0.53) CA2ALDH1A1KDM4ECA1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155740-A1 HETARYLANILINES AS MODULATORS FOR AMYLOID BETA F. Hoffmann-Roche AG (CH) 2010-02-24 EP disclosed
WO-2008138753-A1 HETARYLANILINES AS MODULATORS FOR AMYLOID BETA F. HOFFMANN-LA ROCHE AG (CH) 2008-11-20 WO disclosed